| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &... |
| 01/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 01/04/2023 |
4
| Gottschalk Emily (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 01/04/2023 |
4
| Catelani Michael (President, COO & CFO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 350,000 options to buy
@ $4.19, valued at
$1.5M
|
|
| 01/04/2023 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 01/04/2023 |
4
| Baskies Arnold M (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 01/04/2023 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 700,000 options to buy
@ $4.19, valued at
$2.9M
|
|
| 01/04/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 01/04/2023 |
10-K
| Annual Report for the period ended October 31, 2022 |
| 12/08/2022 |
8-K
| Quarterly results |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2022 |
8-K
| Quarterly results |
| 09/20/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/16/2022 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Paid exercise price by delivering 491,900 shares
@ $4.48, valued at
$2.2M
Exercised 640,000 options to buy
@ $2.575, valued at
$1.6M
|
|
| 09/16/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Gifted 300,000 shares
@ $0 |
|
| 09/12/2022 |
DEL AM
| Form DEL AM - Delaying amendment: |
| 09/09/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 09/09/2022 |
10-Q
| Quarterly Report for the period ended July 31, 2022 |
| 08/17/2022 |
8-K
| Quarterly results |
| 06/28/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Exercised 30,000 options to buy
@ $2.575, valued at
$77.3k
Exercised 16,000 options to buy
@ $2.575, valued at
$41.2k
|
|
| 06/10/2022 |
10-Q
| Quarterly Report for the period ended April 30, 2022 |
| 05/02/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Acquired 1,086 shares
@ $2.76, valued at
$3k
|
|
| 04/27/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 10,000 shares
@ $2.79, valued at
$27.9k
|
|
| 04/22/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 5,500 shares
@ $2.66, valued at
$14.6k
|
|
| 04/21/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 2,509 shares
@ $2.53, valued at
$6.3k
|
|
| 04/15/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 100,000 options to buy
@ $2.62, valued at
$262k
|
|
| 04/15/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|